Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

Jiangsu CoWin Biotech Statistics

Total Valuation

SHA:688426 has a market cap or net worth of CNY 2.47 billion. The enterprise value is 1.87 billion.

Market Cap	2.47B
Enterprise Value	1.87B

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

SHA:688426 has 109.93 million shares outstanding. The number of shares has increased by 0.24% in one year.

Current Share Class	109.93M
Shares Outstanding	109.93M
Shares Change (YoY)	+0.24%
Shares Change (QoQ)	-3.57%
Owned by Insiders (%)	0.16%
Owned by Institutions (%)	13.51%
Float	35.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.67
PB Ratio	1.69
P/TBV Ratio	1.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.41
EV / Sales	13.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.81

Financial Position

The company has a current ratio of 11.41, with a Debt / Equity ratio of 0.02.

Current Ratio	11.41
Quick Ratio	9.67
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	-138.68

Financial Efficiency

Return on equity (ROE) is -9.95% and return on invested capital (ROIC) is -7.20%.

Return on Equity (ROE)	-9.95%
Return on Assets (ROA)	-6.75%
Return on Invested Capital (ROIC)	-7.20%
Return on Capital Employed (ROCE)	-11.92%
Revenue Per Employee	168,161
Profits Per Employee	-181,255
Employee Count	833
Asset Turnover	0.08
Inventory Turnover	1.61

Taxes

Income Tax	-4.87M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.76% in the last 52 weeks. The beta is 0.73, so SHA:688426's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	+44.76%
50-Day Moving Average	21.18
200-Day Moving Average	22.32
Relative Strength Index (RSI)	56.31
Average Volume (20 Days)	1,085,295

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688426 had revenue of CNY 140.08 million and -150.99 million in losses. Loss per share was -1.36.

Revenue	140.08M
Gross Profit	68.21M
Operating Income	-182.39M
Pretax Income	-159.38M
Net Income	-150.99M
EBITDA	-152.76M
EBIT	-182.39M
Loss Per Share	-1.36

Balance Sheet

The company has 650.10 million in cash and 28.85 million in debt, giving a net cash position of 621.25 million or 5.65 per share.

Cash & Cash Equivalents	650.10M
Total Debt	28.85M
Net Cash	621.25M
Net Cash Per Share	5.65
Equity (Book Value)	1.46B
Book Value Per Share	13.11
Working Capital	759.74M

Cash Flow

In the last 12 months, operating cash flow was -102.73 million and capital expenditures -43.51 million, giving a free cash flow of -146.23 million.

Operating Cash Flow	-102.73M
Capital Expenditures	-43.51M
Free Cash Flow	-146.23M
FCF Per Share	-1.33

Margins

Gross margin is 48.70%, with operating and profit margins of -130.21% and -107.79%.

Gross Margin	48.70%
Operating Margin	-130.21%
Pretax Margin	-113.78%
Profit Margin	-107.79%
EBITDA Margin	-109.05%
EBIT Margin	-130.21%
FCF Margin	n/a

Dividends & Yields

SHA:688426 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.24%
Shareholder Yield	n/a
Earnings Yield	-6.10%
FCF Yield	-5.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 12, 2023. It was a forward split with a ratio of 1.2000048.

Last Split Date	Jun 12, 2023
Split Type	Forward
Split Ratio	1.2000048

Scores

SHA:688426 has an Altman Z-Score of 10.28 and a Piotroski F-Score of 2.

Altman Z-Score	10.28
Piotroski F-Score	2